ProPhase Labs, Inc. ( PRPH) - Key Metrics
PRPH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.02 | -$0.16 | -$0.52 | -$0.52 |
| 2025Q2 | $0.03 | -$0.11 | -$0.02 | -$0.02 |
| 2025Q1 | $0.08 | $0.21 | -$0.18 | -$0.18 |
| 2024Q4 | -$0.12 | -$1.68 | $0.11 | $0.12 |
PRPH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -0.70 |
| 2025Q2 | ? | -0.91 |
| 2025Q1 | ? | 0.49 |
| 2024Q4 | ? | -0.11 |
PRPH Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 455.60% | ? |
| 2025Q3 | -113.13% | ? |
| 2025Q2 | -1.52% | ? |
| 2025Q1 | -43.86% | ? |
| 2024Q4 | 15.49% | ? |
PRPH
Price: $0.06
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.75 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 65100
Ebitda: -2.3 millionMarket Capitalization: 342486
Average Dividend Frequency: 1